Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity

BACKGROUND: In mid-December 2020, Israel started a nationwide mass vaccination campaign against coronavirus disease 2019 (COVID-19). In the first few weeks, medical personnel, elderly citizens, and patients with chronic diseases were prioritized. As such, patients with primary and secondary immunode...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Allergy Clin Immunol
Päätekijät: Hagin, David, Freund, Tal, Navon, Michal, Halperin, Tami, Adir, Dikla, Marom, Rotem, Levi, Inbar, Benor, Shira, Alcalay, Yifat, Freund, Natalia T.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Academy of Allergy, Asthma & Immunology 2021
Aiheet:
Covid-19
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8168345/
https://ncbi.nlm.nih.gov/pubmed/34087242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2021.05.029
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia